NOS3 and gastric adenocarcinoma: We found that among the six tumor types expressed higher NOS3 level, NOS3 mRNA was related to a worse prognosis in patients with STAD (median survival: 1,686 vs. 801, p = 0.0133385, HR = 1.394) (Figure 4B).